Annual Net Income
$23.92 M
+$95.58 M+133.37%
December 31, 2023
Summary
- As of February 7, 2025, RDHL annual net profit is $23.92 million, with the most recent change of +$95.58 million (+133.37%) on December 31, 2023.
- During the last 3 years, RDHL annual net income has risen by +$100.09 million (+131.40%).
- RDHL annual net income is now at all-time high.
Performance
RDHL Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Net Income
N/A
June 1, 2024
Summary
- RDHL quarterly net profit is not available.
Performance
RDHL Quarterly Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
TTM Net Income
N/A
June 1, 2024
Summary
- RDHL TTM net profit is not available.
Performance
RDHL TTM Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Net Income Formula
Net Income = Revenue − COGS − Operating Expenses − Interest − Taxes − Other Expenses
RDHL Net Income Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +133.4% | - | - |
| 3 y3 years | +131.4% | - | - |
| 5 y5 years | +161.6% | - | - |
RDHL Net Income Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +124.5% | ||||
| 5 y | 5-year | at high | +124.5% | ||||
| alltime | all time | at high | +124.5% |
RedHill Biopharma Net Income History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2023 | $23.92 M(-133.4%) | - | - |
| Jun 2023 | - | $761.00 K(-98.5%) | $11.57 M(-1385.8%) |
| Mar 2023 | - | $50.24 M(-1447.3%) | -$900.00 K(-98.7%) |
| Dec 2022 | -$71.67 M(-26.7%) | -$3.73 M(-89.6%) | -$71.67 M(-22.4%) |
| Sep 2022 | - | -$35.70 M(+204.9%) | -$92.31 M(+18.4%) |
| Jun 2022 | - | -$11.71 M(-43.0%) | -$78.00 M(-18.2%) |
| Mar 2022 | - | -$20.53 M(-15.8%) | -$95.41 M(-2.4%) |
| Dec 2021 | -$97.74 M(+28.3%) | -$24.37 M(+14.0%) | -$97.74 M(+0.0%) |
| Sep 2021 | - | -$21.39 M(-26.6%) | -$97.70 M(+2.9%) |
| Jun 2021 | - | -$29.12 M(+27.4%) | -$94.95 M(+16.0%) |
| Mar 2021 | - | -$22.86 M(-6.0%) | -$81.88 M(+7.5%) |
| Dec 2020 | -$76.17 M(+80.1%) | -$24.33 M(+30.5%) | -$76.17 M(+19.9%) |
| Sep 2020 | - | -$18.64 M(+16.1%) | -$63.53 M(+16.1%) |
| Jun 2020 | - | -$16.05 M(-6.5%) | -$54.73 M(+10.4%) |
| Mar 2020 | - | -$17.16 M(+46.8%) | -$49.59 M(+17.2%) |
| Dec 2019 | -$42.30 M(+9.0%) | -$11.69 M(+18.9%) | -$42.30 M(+10.5%) |
| Sep 2019 | - | -$9.84 M(-9.8%) | -$38.30 M(-0.6%) |
| Jun 2019 | - | -$10.91 M(+10.5%) | -$38.55 M(-0.5%) |
| Mar 2019 | - | -$9.87 M(+28.4%) | -$38.76 M(-0.2%) |
| Dec 2018 | -$38.82 M(-14.8%) | -$7.68 M(-23.8%) | -$38.82 M(-6.6%) |
| Sep 2018 | - | -$10.08 M(-9.3%) | -$41.55 M(-11.6%) |
| Jun 2018 | - | -$11.12 M(+11.9%) | -$46.98 M(+0.2%) |
| Mar 2018 | - | -$9.94 M(-4.6%) | -$46.88 M(+2.9%) |
| Dec 2017 | -$45.54 M | -$10.41 M(-32.9%) | -$45.54 M(+4.7%) |
| Sep 2017 | - | -$15.51 M(+40.7%) | -$43.48 M(+17.8%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2017 | - | -$11.02 M(+28.2%) | -$36.91 M(+13.8%) |
| Mar 2017 | - | -$8.60 M(+2.9%) | -$32.44 M(+10.5%) |
| Dec 2016 | -$29.37 M(+39.3%) | -$8.35 M(-6.6%) | -$29.37 M(+6.5%) |
| Sep 2016 | - | -$8.94 M(+36.5%) | -$27.58 M(+25.8%) |
| Jun 2016 | - | -$6.55 M(+18.6%) | -$21.93 M(-0.2%) |
| Mar 2016 | - | -$5.52 M(-15.8%) | -$21.97 M(+4.2%) |
| Dec 2015 | -$21.09 M(+96.9%) | -$6.56 M(+99.3%) | -$21.09 M(+6.2%) |
| Sep 2015 | - | -$3.29 M(-50.1%) | -$19.86 M(-4.5%) |
| Jun 2015 | - | -$6.60 M(+42.1%) | -$20.80 M(+11.1%) |
| Mar 2015 | - | -$4.64 M(-12.9%) | -$18.73 M(+74.9%) |
| Dec 2014 | -$10.71 M(+0.8%) | -$5.33 M(+25.8%) | -$10.71 M(+21.4%) |
| Sep 2014 | - | -$4.24 M(-6.4%) | -$8.82 M(+21.1%) |
| Jun 2014 | - | -$4.52 M(-234.0%) | -$7.29 M(+38.1%) |
| Mar 2014 | - | $3.38 M(-198.2%) | -$5.27 M(-50.4%) |
| Dec 2013 | -$10.63 M(+2.9%) | -$3.44 M(+27.5%) | -$10.63 M(+0.8%) |
| Sep 2013 | - | -$2.70 M(+7.4%) | -$10.54 M(+7.5%) |
| Jun 2013 | - | -$2.51 M(+27.1%) | -$9.81 M(+2.5%) |
| Mar 2013 | - | -$1.98 M(-41.0%) | -$9.57 M(-7.3%) |
| Dec 2012 | -$10.33 M(-33.4%) | -$3.35 M(+70.4%) | -$10.33 M(+7.6%) |
| Sep 2012 | - | -$1.97 M(-13.5%) | -$9.59 M(-7.4%) |
| Jun 2012 | - | -$2.27 M(-16.9%) | -$10.36 M(+28.1%) |
| Mar 2012 | - | -$2.73 M(+4.4%) | -$8.08 M(+51.1%) |
| Dec 2011 | -$15.50 M(+509.4%) | -$2.62 M(-4.0%) | -$5.35 M(+96.0%) |
| Sep 2011 | - | -$2.73 M | -$2.73 M |
| Dec 2010 | -$2.54 M | - | - |
FAQ
- What is RedHill Biopharma annual net profit?
- What is the all time high annual net income for RedHill Biopharma?
- What is RedHill Biopharma annual net income year-on-year change?
- What is the all time high quarterly net income for RedHill Biopharma?
- What is the all time high TTM net income for RedHill Biopharma?
What is RedHill Biopharma annual net profit?
The current annual net income of RDHL is $23.92 M
What is the all time high annual net income for RedHill Biopharma?
RedHill Biopharma all-time high annual net profit is $23.92 M
What is RedHill Biopharma annual net income year-on-year change?
Over the past year, RDHL annual net profit has changed by +$95.58 M (+133.37%)
What is the all time high quarterly net income for RedHill Biopharma?
RedHill Biopharma all-time high quarterly net profit is $50.24 M
What is the all time high TTM net income for RedHill Biopharma?
RedHill Biopharma all-time high TTM net profit is $11.57 M